CHICAGO (Reuters) -A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of ...
Following the lead of French pharmaceutical giant Sanofi, Pfizer has agreed to settle more than 10,000 personal-injury claims from users of heartburn drug Zantac, resolving litigation in several U.S.
Forbes contributors publish independent expert analyses and insights. I write about strategy. With this frenzy in mind, GSK executives are unlikely to find much cause to celebrate Zantac today. Forty ...
June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for plaintiffs ...
(Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause ...
The U.S. Food and Drug Administration announced Wednesday a request for all manufacturers to withdraw all prescription and over-the-counter ranitidine drugs from the market immediately, including the ...
Walmart has become the latest store to halt sales of the popular heartburn treatment Zantac after health regulators warned about a potentially dangerous contaminant in the drug. The nation's largest ...
Add Yahoo as a preferred source to see more of our stories on Google. Fans of the popular heartburn medication ranitidine (known by the brand name Zantac) were shocked earlier this week when the Food ...
(Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.
Delaware—the first of the 13 colonies to ratify the U.S. Constitution—also prides itself on being the state of incorporation for "more than 66% of the Fortune 500." The Delaware Supreme Court recently ...
Several drug stocks are getting hit today on concerns of exposure to litigation related to Zantac, a heartburn medicine that was removed from the U.S. markets in 2020 after the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results